BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 32064884)

  • 1. MiR-769-5p inhibits cancer progression in oral squamous cell carcinoma by directly targeting JAK1/STAT3 pathway.
    Zhou Y; Xu XM; Feng Y
    Neoplasma; 2020 May; 67(3):528-536. PubMed ID: 32064884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkannin restrains oral squamous carcinoma cell growth, migration and invasion by regulating microRNA-9/RECK axis.
    Mao Y; Zhang W; Zhang R; Zuo J
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3153-3162. PubMed ID: 31349748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
    Han L; Cheng J; Li A
    Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
    [No Abstract]   [Full Text] [Related]  

  • 4. Extract of
    Huang X; Chen Y; Zhang X; Li F; Ye H
    Cancer Biother Radiopharm; 2020 Oct; 35(8):586-595. PubMed ID: 32486841
    [No Abstract]   [Full Text] [Related]  

  • 5. MiR-503-5p functions as an oncogene in oral squamous cell carcinoma by targeting Smad7.
    Fei Y; Shan W; Chen X
    Histol Histopathol; 2020 Aug; 35(8):893-901. PubMed ID: 32319077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosome-mediated long noncoding RNA (lncRNA) PART1 suppresses malignant progression of oral squamous cell carcinoma via miR-17-5p/SOCS6 axis.
    Du Y; Shuai Y; Wang H; Li H; Li Y
    Turk J Med Sci; 2023 Jun; 53(3):630-639. PubMed ID: 37476905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma.
    Tan J; Xiang L; Xu G
    IUBMB Life; 2019 Jul; 71(7):882-890. PubMed ID: 30809930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA DANCR regulates the growth and metastasis of oral squamous cell carcinoma cells via altering miR-216a-5p expression.
    Qu XH; Shi YL; Ma Y; Bao WW; Yang L; Li JC; Zhang F
    Hum Cell; 2020 Oct; 33(4):1281-1293. PubMed ID: 32860589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression.
    Cao MX; Zhang WL; Yu XH; Wu JS; Qiao XW; Huang MC; Wang K; Wu JB; Tang YJ; Jiang J; Liang XH; Tang YL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):102. PubMed ID: 32493454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. circ_0005379 inhibits the progression of oral squamous cell carcinoma by regulating the miR-17-5p/acyl-CoA oxidase 1 axis.
    Zhou HX; Wang LY; Chen S; Wang DD; Fang Z
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Aug; 39(4):425-433. PubMed ID: 34409798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9.
    Wang K; Jin J; Ma T; Zhai H
    J Cell Mol Med; 2017 Dec; 21(12):3730-3740. PubMed ID: 28780773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting lncRNA PSMA3-AS1, a Prognostic Marker, Suppresses Malignant Progression of Oral Squamous Cell Carcinoma.
    Cao X; Luan K; Yang J; Huang Y
    Dis Markers; 2021; 2021():3138046. PubMed ID: 34457087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-32-5p promoted epithelial-to-mesenchymal transition of oral squamous cell carcinoma cells via regulating the KLF2/CXCR4 pathway.
    Qin SY; Li B; Chen M; Qin MQ; Liu JM; Lv QL
    Kaohsiung J Med Sci; 2022 Feb; 38(2):120-128. PubMed ID: 34741382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KCNQ1OT1 promotes migration and inhibits apoptosis by modulating miR-185-5p/Rab14 axis in oral squamous cell carcinoma.
    Bao Q; Liao X; Li R; Ding N
    Dev Growth Differ; 2019 Dec; 61(9):466-474. PubMed ID: 31755091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect and mechanism of circular RNA BICD2 on the biological behavior of oral squamous cell carcinoma cells].
    Zhang YJ; Zhu QQ; Zhou HX; Wang HY; Zhou H
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Nov; 56(11):1098-1108. PubMed ID: 34763405
    [No Abstract]   [Full Text] [Related]  

  • 17. Circ_0001971 regulates oral squamous cell carcinoma progression and chemosensitivity by targeting miR-194/miR-204 in vitro and in vivo.
    Tan X; Zhou C; Liang Y; Lai YF; Liang Y
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2470-2481. PubMed ID: 32196598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-590-5p regulates cell proliferation, apoptosis, migration and invasion in oral squamous cell carcinoma by targeting RECK.
    Bao WW; Shi YL; Ma Y; Qu XH; Pang GM; Yang L
    Histol Histopathol; 2021 Mar; 36(3):355-365. PubMed ID: 33447989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA BLACAT1 regulates the viability, migration and invasion of oral squamous cell carcinoma cells by targeting miR-142-5p.
    Dai D; Feng XD; Zhu WQ; Bao YN
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10313-10323. PubMed ID: 31841186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of transforming growth factor-beta1 by circANKS1B/miR-515-5p affects the metastatic potential and cisplatin resistance in oral squamous cell carcinoma.
    Yan J; Xu H
    Bioengineered; 2021 Dec; 12(2):12420-12430. PubMed ID: 34781814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.